Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction.

Roux A, Leroy H, De Muylder B, Bracq L, Oussous S, Dusanter-Fourt I, Chougui G, Tacine R, Randriamampita C, Desjardins D, Le Grand R, Bouillaud F, Benichou S, Margottin-Goguet F, Cheynier R, Bismuth G, Mangeney M.

PLoS Pathog. 2019 May 1;15(5):e1007669. doi: 10.1371/journal.ppat.1007669. eCollection 2019 May.

2.

Mechanisms for Cell-to-Cell Transmission of HIV-1.

Bracq L, Xie M, Benichou S, Bouchet J.

Front Immunol. 2018 Feb 19;9:260. doi: 10.3389/fimmu.2018.00260. eCollection 2018. Review.

3.

Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss.

Raynaud-Messina B, Bracq L, Dupont M, Souriant S, Usmani SM, Proag A, Pingris K, Soldan V, Thibault C, Capilla F, Al Saati T, Gennero I, Jurdic P, Jolicoeur P, Davignon JL, Mempel TR, Benichou S, Maridonneau-Parini I, Vérollet C.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2556-E2565. doi: 10.1073/pnas.1713370115. Epub 2018 Feb 20.

4.

Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)200 expansion in the DMPK gene: CHUQi001-A.

Martineau L, Racine V, Benichou SA, Puymirat J.

Stem Cell Res. 2018 Jan;26:103-106. doi: 10.1016/j.scr.2017.12.010. Epub 2017 Dec 16.

5.

T Cell-Macrophage Fusion Triggers Multinucleated Giant Cell Formation for HIV-1 Spreading.

Bracq L, Xie M, Lambelé M, Vu LT, Matz J, Schmitt A, Delon J, Zhou P, Randriamampita C, Bouchet J, Benichou S.

J Virol. 2017 Nov 30;91(24). pii: e01237-17. doi: 10.1128/JVI.01237-17. Print 2017 Dec 15.

6.

The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.

Liu L, Wang W, Matz J, Ye C, Bracq L, Delon J, Kimata JT, Chen Z, Benichou S, Zhou P.

J Virol. 2016 Nov 14;90(23):10642-10659. doi: 10.1128/JVI.01559-16. Print 2016 Dec 1.

7.

Uracil DNA glycosylase interacts with the p32 subunit of the replication protein A complex to modulate HIV-1 reverse transcription for optimal virus dissemination.

Herate C, Vigne C, Guenzel CA, Lambele M, Rouyez MC, Benichou S.

Retrovirology. 2016 Apr 12;13:26. doi: 10.1186/s12977-016-0257-x.

8.

Phospholipid Scramblase 1 Modulates FcR-Mediated Phagocytosis in Differentiated Macrophages.

Herate C, Ramdani G, Grant NJ, Marion S, Gasman S, Niedergang F, Benichou S, Bouchet J.

PLoS One. 2016 Jan 8;11(1):e0145617. doi: 10.1371/journal.pone.0145617. eCollection 2016.

9.

The HIV-1 protein Vpr impairs phagosome maturation by controlling microtubule-dependent trafficking.

Dumas A, Lê-Bury G, Marie-Anaïs F, Herit F, Mazzolini J, Guilbert T, Bourdoncle P, Russell DG, Benichou S, Zahraoui A, Niedergang F.

J Cell Biol. 2015 Oct 26;211(2):359-72. doi: 10.1083/jcb.201503124.

10.
11.

A homogeneous time-resolved fluorescence-based high-throughput screening for discovery of inhibitors of Nef-sdAb19 interaction.

Fan X, Wei J, Xiong H, Liu X, Benichou S, Gao X, Liu L.

Int J Oncol. 2015 Oct;47(4):1485-93. doi: 10.3892/ijo.2015.3132. Epub 2015 Aug 25.

PMID:
26315450
12.

HIV-1 reprograms the migration of macrophages.

Vérollet C, Souriant S, Bonnaud E, Jolicoeur P, Raynaud-Messina B, Kinnaer C, Fourquaux I, Imle A, Benichou S, Fackler OT, Poincloux R, Maridonneau-Parini I.

Blood. 2015 Mar 5;125(10):1611-22. doi: 10.1182/blood-2014-08-596775. Epub 2014 Dec 19.

PMID:
25527710
13.

ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.

Machado-Neto JA, Lazarini M, Favaro P, de Melo Campos P, Scopim-Ribeiro R, Franchi Junior GC, Nowill AE, Lima PR, Costa FF, Benichou S, Olalla Saad ST, Traina F.

Biochim Biophys Acta. 2015 Mar;1853(3):583-93. doi: 10.1016/j.bbamcr.2014.12.012. Epub 2014 Dec 16.

14.

Selection of intracellular single-domain antibodies targeting the HIV-1 Vpr protein by cytoplasmic yeast two-hybrid system.

Matz J, Hérate C, Bouchet J, Dusetti N, Gayet O, Baty D, Benichou S, Chames P.

PLoS One. 2014 Dec 1;9(12):e113729. doi: 10.1371/journal.pone.0113729. eCollection 2014.

15.

HIV-1 Vpr-a still "enigmatic multitasker".

Guenzel CA, Hérate C, Benichou S.

Front Microbiol. 2014 Mar 31;5:127. doi: 10.3389/fmicb.2014.00127. eCollection 2014. Review.

16.

Structural basis for the inhibition of HIV-1 Nef by a high-affinity binding single-domain antibody.

Lülf S, Matz J, Rouyez MC, Järviluoma A, Saksela K, Benichou S, Geyer M.

Retrovirology. 2014 Mar 13;11:24. doi: 10.1186/1742-4690-11-24.

17.

Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Brégnard C, Zamborlini A, Leduc M, Chafey P, Camoin L, Saïb A, Benichou S, Danos O, Basmaciogullari S.

J Virol. 2013 Apr;87(7):3729-40. doi: 10.1128/JVI.02477-12. Epub 2013 Jan 16.

18.

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and coreceptor binding sites of HIV-1 gp120.

Matz J, Kessler P, Bouchet J, Combes O, Ramos OH, Barin F, Baty D, Martin L, Benichou S, Chames P.

J Virol. 2013 Jan;87(2):1137-49. doi: 10.1128/JVI.00461-12. Epub 2012 Nov 14.

19.

High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain.

Järviluoma A, Strandin T, Lülf S, Bouchet J, Mäkelä AR, Geyer M, Benichou S, Saksela K.

PLoS One. 2012;7(7):e40331. doi: 10.1371/journal.pone.0040331. Epub 2012 Jul 5.

20.

Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functions.

Bouchet J, Hérate C, Guenzel CA, Vérollet C, Järviluoma A, Mazzolini J, Rafie S, Chames P, Baty D, Saksela K, Niedergang F, Maridonneau-Parini I, Benichou S.

J Virol. 2012 May;86(9):4856-67. doi: 10.1128/JVI.06329-11. Epub 2012 Feb 15.

21.

Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.

Guenzel CA, Hérate C, Le Rouzic E, Maidou-Peindara P, Sadler HA, Rouyez MC, Mansky LM, Benichou S.

J Virol. 2012 Mar;86(5):2533-44. doi: 10.1128/JVI.05163-11. Epub 2011 Dec 14.

22.

E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.

Fourati S, Malet I, Guenzel CA, Soulie C, Maidou-Peindara P, Morand-Joubert L, Wirden M, Sayon S, Peytavin G, Simon A, Katlama C, Benichou S, Calvez V, Marcelin AG.

Antiviral Res. 2012 Jan;93(1):167-74. doi: 10.1016/j.antiviral.2011.11.008. Epub 2011 Nov 25.

PMID:
22138483
23.

Inhibition of the Nef regulatory protein of HIV-1 by a single-domain antibody.

Bouchet J, Basmaciogullari SE, Chrobak P, Stolp B, Bouchard N, Fackler OT, Chames P, Jolicoeur P, Benichou S, Baty D.

Blood. 2011 Mar 31;117(13):3559-68. doi: 10.1182/blood-2010-07-296749. Epub 2011 Feb 3.

PMID:
21292773
24.

Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins.

Laguette N, Brégnard C, Benichou S, Basmaciogullari S.

Mol Aspects Med. 2010 Oct;31(5):418-33. doi: 10.1016/j.mam.2010.05.003. Epub 2010 Jun 4. Review.

PMID:
20594957
25.

HIV-1 Nef triggers macrophage fusion in a p61Hck- and protease-dependent manner.

Vérollet C, Zhang YM, Le Cabec V, Mazzolini J, Charrière G, Labrousse A, Bouchet J, Medina I, Biessen E, Niedergang F, Bénichou S, Maridonneau-Parini I.

J Immunol. 2010 Jun 15;184(12):7030-9. doi: 10.4049/jimmunol.0903345. Epub 2010 May 19.

26.

Molecular and functional basis for the scaffolding role of the p50/dynamitin subunit of the microtubule-associated dynactin complex.

Jacquot G, Maidou-Peindara P, Benichou S.

J Biol Chem. 2010 Jul 23;285(30):23019-31. doi: 10.1074/jbc.M110.100602. Epub 2010 May 12.

27.

Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments.

Mazzolini J, Herit F, Bouchet J, Benmerah A, Benichou S, Niedergang F.

Blood. 2010 May 27;115(21):4226-36. doi: 10.1182/blood-2009-12-259473. Epub 2010 Mar 18.

PMID:
20299515
28.

Vpr and its interactions with cellular proteins.

Planelles V, Benichou S.

Curr Top Microbiol Immunol. 2009;339:177-200. doi: 10.1007/978-3-642-02175-6_9. Review.

PMID:
20012529
29.

Characterization of the molecular determinants of primary HIV-1 Vpr proteins: impact of the Q65R and R77Q substitutions on Vpr functions.

Jacquot G, Le Rouzic E, Maidou-Peindara P, Maizy M, Lefrère JJ, Daneluzzi V, Monteiro-Filho CM, Hong D, Planelles V, Morand-Joubert L, Benichou S.

PLoS One. 2009 Oct 19;4(10):e7514. doi: 10.1371/journal.pone.0007514.

30.

The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.

Ropars V, Despouy G, Stern MH, Benichou S, Roumestand C, Arold ST.

PLoS One. 2009 Aug 10;4(8):e6567. doi: 10.1371/journal.pone.0006567.

31.

Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.

Langevin C, Maidou-Peindara P, Aas PA, Jacquot G, Otterlei M, Slupphaug G, Benichou S.

J Virol. 2009 Oct;83(19):10256-63. doi: 10.1128/JVI.02654-08. Epub 2009 Jul 22.

32.

Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase.

Laguette N, Brégnard C, Bouchet J, Benmerah A, Benichou S, Basmaciogullari S.

J Virol. 2009 Jul;83(14):7117-28. doi: 10.1128/JVI.01648-08. Epub 2009 May 13.

33.

The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane.

Py B, Basmaciogullari S, Bouchet J, Zarka M, Moura IC, Benhamou M, Monteiro RC, Hocini H, Madrid R, Benichou S.

PLoS One. 2009;4(3):e5006. doi: 10.1371/journal.pone.0005006. Epub 2009 Mar 31. Erratum in: PLoS ONE. 2009;4(4). doi: 10.1371/annotation/657cd713-aaac-4ebb-80ad-3ec8dfb12b42.

34.

Isolation and characterization of microsatellite markers from the phytopathogenic fungus Alternaria dauci.

Benichou S, Dongo A, Henni DE, Peltier D, Simoneau P.

Mol Ecol Resour. 2009 Jan;9(1):390-2. doi: 10.1111/j.1755-0998.2008.02237.x. Epub 2008 Dec 22.

PMID:
21564659
35.

Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.

Laguette N, Benichou S, Basmaciogullari S.

J Virol. 2009 Jan;83(2):1093-104. doi: 10.1128/JVI.01633-08. Epub 2008 Nov 5.

36.

The Diaphanous-related Formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing.

Hannemann S, Madrid R, Stastna J, Kitzing T, Gasteier J, Schönichen A, Bouchet J, Jimenez A, Geyer M, Grosse R, Benichou S, Fackler OT.

J Biol Chem. 2008 Oct 10;283(41):27891-903. doi: 10.1074/jbc.M801800200. Epub 2008 Aug 11.

38.

Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages.

Jacquot G, Le Rouzic E, David A, Mazzolini J, Bouchet J, Bouaziz S, Niedergang F, Pancino G, Benichou S.

Retrovirology. 2007 Nov 26;4:84.

39.

The Siva protein is a novel intracellular ligand of the CD4 receptor that promotes HIV-1 envelope-induced apoptosis in T-lymphoid cells.

Py B, Bouchet J, Jacquot G, Sol-Foulon N, Basmaciogullari S, Schwartz O, Biard-Piechaczyk M, Benichou S.

Apoptosis. 2007 Oct;12(10):1879-92.

PMID:
17653867
40.

Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane.

Burtey A, Rappoport JZ, Bouchet J, Basmaciogullari S, Guatelli J, Simon SM, Benichou S, Benmerah A.

Traffic. 2007 Jan;8(1):61-76. Epub 2006 Nov 28.

41.

HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.

Andersen JL, DeHart JL, Zimmerman ES, Ardon O, Kim B, Jacquot G, Benichou S, Planelles V.

PLoS Pathog. 2006 Dec;2(12):e127.

42.

Development and characterization of ten monoclonal anti-Vpr antibodies.

Sabbah EN, Delaunay T, Varin A, Le-Rouzic E, Benichou S, Herbein G, Druillennec S, Roques BP.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):630-9.

PMID:
16831087
43.

Modulation of cellular protein trafficking by human immunodeficiency virus type 1 Nef: role of the acidic residue in the ExxxLL motif.

Coleman SH, Madrid R, Van Damme N, Mitchell RS, Bouchet J, Servant C, Pillai S, Benichou S, Guatelli JC.

J Virol. 2006 Feb;80(4):1837-49.

44.

Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import.

Mannioui A, Nelson E, Schiffer C, Felix N, Le Rouzic E, Benichou S, Gluckman JC, Canque B.

Virology. 2005 Aug 15;339(1):21-30.

45.

FHOD1 coordinates actin filament and microtubule alignment to mediate cell elongation.

Gasteier JE, Schroeder S, Muranyi W, Madrid R, Benichou S, Fackler OT.

Exp Cell Res. 2005 May 15;306(1):192-202.

PMID:
15878344
46.

The Vpr protein from HIV-1: distinct roles along the viral life cycle.

Le Rouzic E, Benichou S.

Retrovirology. 2005 Feb 22;2:11. Review.

47.

Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes.

Coleman SH, Van Damme N, Day JR, Noviello CM, Hitchin D, Madrid R, Benichou S, Guatelli JC.

J Virol. 2005 Feb;79(4):2066-78.

48.

Oligomerization of the diaphanous-related formin FHOD1 requires a coiled-coil motif critical for its cytoskeletal and transcriptional activities.

Madrid R, Gasteier JE, Bouchet J, Schröder S, Geyer M, Benichou S, Fackler OT.

FEBS Lett. 2005 Jan 17;579(2):441-8.

49.

Putative homeodomain transcription factor 1 interacts with the feminization factor homolog fem1b in male germ cells.

Oyhenart J, Benichou S, Raich N.

Biol Reprod. 2005 Apr;72(4):780-7. Epub 2004 Dec 15.

PMID:
15601915
50.

Nef-induced alteration of the early/recycling endosomal compartment correlates with enhancement of HIV-1 infectivity.

Madrid R, Janvier K, Hitchin D, Day J, Coleman S, Noviello C, Bouchet J, Benmerah A, Guatelli J, Benichou S.

J Biol Chem. 2005 Feb 11;280(6):5032-44. Epub 2004 Nov 29.

Supplemental Content

Loading ...
Support Center